Public Alert No. 09/2025 – Voluntary Recall of Zovirax IV Infusion by GlaxoSmithKline (GSK) Limited Due to Potential Quality Defects
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public that GlaxoSmithKline (GSK) Limited has voluntarily recalled one lot of Zovirax IV Infusion 250mg RN3T in Hong Kong due to potential quality defects. The Department of Health (DH) Hong Kong received notification from GSK that its branch in Taiwan is […]